What You Should Know About Cell Line Development To Ensure A Successful Launch
Source: Samsung Biologics
By Yongho Ahn, Vice President, Head of CDO R&D at Samsung Biologics and John Gill, Director, Cell Line Development at Samsung Biologics

access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
Samsung Biologics
This website uses cookies to ensure you get the best experience on our website. Learn more